Posted by Michael Wonder on 04 Oct 2016
Did it matter that the Cancer Drugs Fund was not NICE? A retrospective review
3 October 2016 - This article reviews the means by which the Cancer Drugs Fund made recent funding decisions for cancer drugs in order to provide an assessment of the merits of the Cancer Drugs Fund model as a basis for allocation decisions.
